EDITORIALS

Epidermal Growth Factor Receptor and Epidermal Growth Factor Receptor Therapies in Renal Cell Carcinoma: Do We Need a Better Mouse Trap?

Janet E. Dancey

JCO Aug 1 2004: 2975–2977. First published on Jun 21 2004; 10.1200/JCO.2004.04.934. [Full Text] [PDF]

Substitution of Oral Fluoropyrimidines for Infusional Fluorouracil With Radiotherapy: How Much Data Do We Need?

Christopher H. Crane and Daniel J. Sargent

JCO Aug 1 2004: 2978–2981. First published on Jun 21 2004; 10.1200/JCO.2004.04.953. [Full Text] [PDF]

The Limits of Limited Stage Lymphoma

Thomas P. Miller

JCO Aug 1 2004: 2982–2984. First published on Jun 21 2004; 10.1200/JCO.2004.05.926. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

Developing a System to Assess the Quality of Cancer Care: ASCO's National Initiative on Cancer Care Quality

Eric C. Schneider, Arnold M. Epstein, Jennifer L. Malin, Katherine L. Kahn, and Ezekiel J. Emanuel

JCO Aug 1 2004: 2985–2991. [Full Text] [PDF]

Understanding Cancer Treatment and Outcomes: The Cancer Care Outcomes Research and Surveillance Consortium

John Z. Ayanian, Elizabeth A. Chrischilles, Robert B. Wallace, Robert H. Fletcher, Mona N. Fouad, Catarina I. Kiefe, David P. Harrington, Jane C. Weeks, Katherine L. Kahn, Jennifer L. Malin, Joseph Lipscomb, Arnold L. Potosky, Dawn T. Provenzale, Robert S. Sandler, Michelle van Ryn, and Dee W. West

JCO Aug 1 2004: 2992–2996. [Full Text] [PDF]

Managing Accrual in Cooperative Group Clinical Trials

Todd L. Demmy, Joyce M. Yasko, Deborah E. Collyar, Mira L. Katz, Carol L. Krasnov, Margaret J. Borwhat, Anne Battershell, and Stephen L. George

JCO Aug 1 2004: 2997–3002. [Full Text] [PDF]

ORIGINAL REPORTS
Genitourinary Cancer
	Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer
	Eric K. Rowinsky, Garry H. Schwartz, Jared A. Gollob, John A. Thompson, Nicholas J. Vogelzang, Robert Figlin, Ronald Bukowski, Naomi Haas, Pamela Lockbaum, Yu-Ping Li, Rosalin Arends, Kenneth A. Foon, Gisela Schwab, and Janice Dutcher
	JCO Aug 1 2004: 3003–3015. First published on Jun 21 2004; 10.1200/JCO.2004.11.061. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Preoperative Uracil, Tegafur, and Concomitant Radiotherapy in Operable Rectal Cancer: A Phase II Multicenter Study With 3 Years' Follow-Up
	Carlos Fernández-Martos, Jorge Aparicio, Carles Bosch, Marilo Torregrosa, Juan Manuel Campos, Salvador Garcera, Jose Maria Vicent, Inmaculada Maestu, Miguel Angel Climent, Jose Luis Mengual, Alejandro Tormo, Ana Hernandez, Rafael Estevan, Jose Maria Richart, Vicente Viciano, Natalia Uribe, Jorge Campos, Ramon Puchades, Francisco Arlandis, and Daniel Almenar
	JCO Aug 1 2004: 3016–3022. First published on Jun 21 2004; 10.1200/JCO.2004.11.124. [Abstract] [Full Text] [PDF]
	A Randomized Trial Comparing Defined-Duration With Continuous Irinotecan Until Disease Progression in Fluoropyrimidine and Thymidylate Synthase Inhibitor—Resistant Advanced Colorectal Cancer
	Rohit Lal, James Dickson, David Cunningham, Ian Chau, Andrew R. Norman, Paul J. Ross, Clare Topham, Gary Middleton, Mark Hill, and Jacqui Oates
	JCO Aug 1 2004: 3023–3031. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484
	Sandra J. Horning, Edie Weller, KyungMann Kim, John D. Earle, Michael J. O'Connell, Thomas M. Habermann, and John H. Glick
	JCO Aug 1 2004: 3032–3038. First published on Jun 21 2004; 10.1200/JCO.2004.06.088. [Abstract] [Full Text] [PDF]
	Ongoing Monoclonal B-Cell Proliferation Is Not Common in Gastric B-Cell Lymphoma After Combined Radiochemotherapy
	Birgit Alpen, Rolf Kuse, Radzak Parwaresch, Hans Konrad Müller-Hermelink, Manfred Stolte, and Andreas Neubauer
	JCO Aug 1 2004: 3039–3045. [Abstract] [Full Text] [PDF]
	Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma
	Sean T. Hehn, Thomas M. Grogan, and Thomas P. Miller
	JCO Aug 1 2004: 3046–3052. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
	Anthony T.C. Chan, Brigette B.Y. Ma, Y.M. Dennis Lo, S.F. Leung, W.H. Kwan, Edwin P. Hui, Tony S.K. Mok, Michael Kam, Lisa S. Chan, Samuel K.W. Chiu, K.H. Yu, K.Y. Cheung, Karen Lai, Maria Lai, Frankie Mo, Winnie Yeo, Ann King, Philip J. Johnson, Peter M.L. Teo, and Benny Zee
	JCO Aug 1 2004: 3053–3060. [Abstract] [Full Text] [PDF]
	Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up
	A. Psyrri, M. Kwong, S. DiStasio, L. Lekakis, M. Kassar, C. Sasaki, L.D. Wilson, B.G. Haffty, Y.H. Son, D.A. Ross, P.M. Weinberger, G.G. Chung, D. Zelterman, B.A. Burtness, and D.L. Cooper
	JCO Aug 1 2004: 3061–3069. [Abstract] [Full Text] [PDF]

Breast Cancer
	Long-Term Cardiac Follow-Up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, As Adjuvant Therapy for Node-Positive Breast Cancer: French Adjuvant Study Group
	Jacques Bonneterre, Henri Roché, Pierre Kerbrat, Pierre Fumoleau, Marie-Josèphe Goudier, Pierre Fargeot, Philippe Montcuquet, Pierre Clavère, Jean-Claude Barats, Alain Monnier, Corinne Veyret, Jean Datchary, Isabelle Van Praagh, and Isabelle Chapelle-Marcillac
	JCO Aug 1 2004: 3070–3079. [Abstract] [Full Text] [PDF]
	Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
	Antoinette R. Tan, Xiaowei Yang, Stephen M. Hewitt, Arlene Berman, Erin R. Lepper, Alex Sparreboom, Allyson L. Parr, William D. Figg, Catherine Chow, Seth M. Steinberg, Stephen L. Bacharach, Millie Whatley, Jorge A. Carrasquillo, Jaime S. Brahim, Seth A. Ettenberg, Stan Lipkowitz, and Sandra M. Swain
	JCO Aug 1 2004: 3080–3090. [Abstract] [Full Text] [PDF]
	Patient-Physician Concordance: Preferences, Perceptions, and Factors Influencing the Breast Cancer Surgical Decision
	Nancy K. Janz, Patricia A. Wren, Laurel A. Copeland, Julie C. Lowery, Sherry L. Goldfarb, and Edwin G. Wilkins
	JCO Aug 1 2004: 3091–3098. [Abstract] [Full Text] [PDF]

Epidemiology
	Differential Prognostic Impact of Comorbidity
	William L. Read, Ryan M. Tierney, Nathan C. Page, Irene Costas, Ramaswamy Govindan, Edward L.J. Spitznagel, and Jay F. Piccirillo
	JCO Aug 1 2004: 3099–3103. [Abstract] [Full Text] [PDF]
	High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened Cohort
	Pär Stattin, Sabina Rinaldi, Carine Biessy, Ulf-Håkan Stenman, Göran Hallmans, and Rudolf Kaaks
	JCO Aug 1 2004: 3104–3112. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
	David H. Moore, John A. Blessing, Richard P. McQuellon, Howard T. Thaler, David Cella, Jo Benda, David S. Miller, George Olt, Stephanie King, John F. Boggess, and Thomas F. Rocereto
	JCO Aug 1 2004: 3113–3119. [Abstract] [Full Text] [PDF]
	Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial Design
	Maurie Markman, Jonathan Markman, Kenneth Webster, Kristine Zanotti, Barbara Kulp, Gertrude Peterson, and Jerome Belinson
	JCO Aug 1 2004: 3120–3125. [Abstract] [Full Text] [PDF]
	Her-2/neu Overexpression and Amplification in Uterine Papillary Serous Carcinoma
	Brian M. Slomovitz, Russell R. Broaddus, Thomas W. Burke, Nour Sneige, Pamela T. Soliman, Weiguo Wu, Charlotte C. Sun, Mark F. Munsell, David M. Gershenson, and Karen H. Lu
	JCO Aug 1 2004: 3126–3132. [Abstract] [Full Text] [PDF]

Neurooncology
	Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
	K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Crinière, Y. Marie, K. Mokhtari, A.F. Carpentier, F. Laigle, J.M. Simon, P. Cornu, P. Broët, M. Sanson, and J.Y. Delattre
	JCO Aug 1 2004: 3133–3138. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest Radiotherapy
	M. Jacob Adams, Stuart R. Lipsitz, Steven D. Colan, Nancy J. Tarbell, S. Ted Treves, Lisa Diller, Nina Greenbaum, Peter Mauch, and Steven E. Lipshultz
	JCO Aug 1 2004: 3139–3148. [Abstract] [Full Text] [PDF]
	Using Health-Related Quality of Life Measures to Predict Cardiac Function in Survivors Exposed to Anthracyclines
	Jill P. Ginsberg, Avital Cnaan, Huaqing Zhao, Bernard J. Clark, Stephen M. Paridon, Alvin J. Chin, Jack Rychik, Alexa N. Hogarty, Gerald Barber, Monika Rutkowski, Thomas R. Kimball, Cynthia DeLaat, Laurel J. Steinherz, and Jeffrey H. Silber
	JCO Aug 1 2004: 3149–3155. [Abstract] [Full Text] [PDF]
	Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized Ependymoma
	Thomas E. Merchant, Raymond K. Mulhern, Matthew J. Krasin, Larry E. Kun, Tani Williams, Chenghong Li, Xiaoping Xiong, Raja B. Khan, Robert H. Lustig, Frederick A. Boop, and Robert A. Sanford
	JCO Aug 1 2004: 3156–3162. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Long-Term Silicone Central Venous Catheters Impregnated With Minocycline and Rifampin Decrease Rates of Catheter-Related Bloodstream Infection in Cancer Patients: A Prospective Randomized Clinical Trial
	Hend Hanna, Robert Benjamin, Ioannis Chatzinikolaou, Badie Alakech, Deborah Richardson, Paul Mansfield, Tanya Dvorak, Mark F. Munsell, Rabih Darouiche, Hagop Kantarjian, and Issam Raad
	JCO Aug 1 2004: 3163–3171. [Abstract] [Full Text] [PDF]
	Assessing Quality of Life During Chemotherapy for Pleural Mesothelioma: Feasibility, Validity, and Results of Using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module
	Anna K. Nowak, Martin R. Stockler, and Michael J. Byrne
	JCO Aug 1 2004: 3172–3180. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Review of Determinants of Patients’ Preferences for Adjuvant Therapy in Cancer
	Sylvia J.T. Jansen, Wilma Otten, and Anne M. Stiggelbout
	JCO Aug 1 2004: 3181–3190. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Uncommon Manifestations of Common Malignancies: CASE 1. Soft-Tissue Metastases From Malignant Pleural Mesothelioma

Hector Soto Parra, Paolo Andrea Zucali, Piergiuseppe Colombo, Luca Balzarini, and Armando Santoro

JCO Aug 1 2004: 3191–3192. [Full Text] [PDF]

Uncommon Manifestations of Common Malignancies: CASE 2. Chronic Lymphocytic Leukemia and Multiple Myeloma in the Same Patient

V. Lakshmi Devi, Kumar Prabhash, M. Malathi, D.S. Madhumathi, and P.P. Bapsy

JCO Aug 1 2004: 3192–3193. [Full Text] [PDF]

Uncommon Manifestations of Common Malignancies: CASE 3. Malignant Melanoma Arising From a Spinal Nerve Root

Aung Naing, Jane L. Messina, Frank R. Vrionis, and Adil I. Daud

JCO Aug 1 2004: 3194–3195. [Full Text] [PDF]

ART OF ONCOLOGY

Reassurance

David P. Steensma

JCO Aug 1 2004: 3196–3198. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Phase III Study of Letrozole Versus Tamoxifen As First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Aman U. Buzdar

JCO Aug 1 2004: 3199–3200. [Full Text] [PDF]

In Reply:

Henning Mouridsen and Hilary A. Chaudri-Ross

JCO Aug 1 2004: 3200–3201. [Full Text] [PDF]

Free Circulating DNA: Good As a Diagnostic Marker in Lung Cancer?

Ozden Altundag, Kadri Altundag, and Muzaffer Altundag

JCO Aug 1 2004: 3201–3202. [Full Text] [PDF]

In Reply:

Ugo Pastorino, Luca Roz, Gabriella Sozzi, and MariaElena Leon

JCO Aug 1 2004: 3202. [Full Text] [PDF]

Oxaliplatin Toxicity Masquerading As Recurrent Colon Cancer

Glenn Tisman, Douglas MacDonald, Neil Shindell, Edward Reece, Paresh Patel, Nathan Honda, Earl K. Nishimora, Joel Garris, William Shannahan, Nadeem Chisti, John McCarthy, Shahriare Nasser Moaddeli, Dennis Sargent, and Ashley Plant

JCO Aug 1 2004: 3202-a–3204. [Full Text] [PDF]

Errata

ERRATUM

JCO Aug 1 2004: 3205. [Full Text] [PDF]

ERRATUM

JCO Aug 1 2004: 3205-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.